DNTH vs FTV · rev $6.2M vs P/E 31, rev $6.23B
Dianthus Therapeutics Inc. (DNTH) versus Fortive Corp (FTV) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Fortive Corp (FTV) is a scientific & technical instruments company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported FTV revenue for 2024-12-31 was $6.23B. Net income was $832.9M. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FTV currently screens at market cap $24.34B and trailing P/E 31.4.
DNTH currently screens at market cap $4.40B. FTV currently screens at market cap $24.34B and trailing P/E 31.4.
Not investment advice. Open the DNTH and FTV stock pages for the full models.
Not investment advice.